December 18, 2013
A study by UC Davis MIND Institute researchers has been named one of the Top 10 Scientific Advances of 2013 by Autism Speaks, the international science and advocacy organization.
December 12, 2013
Alessio Fasano, an internationally respected pediatric gastroenterologist, research scientist and founder of the Center for Celiac Research at MassGeneral Hospital for Children, will present “Gut-brain interaction in autism spectrum disorder: What language do they speak, and do they understand each other?” during the January 2014 UC Davis MIND Institute distinguished lecture.
December 9, 2013
November 20, 2013
"Fragile X-Associated Disorders: A Woman’s View from the Heart of the Family," is the topic of the December UC Davis MIND Institute Distinguished Lecture Series presentation.
November 6, 2013
Children with autism experience gastrointestinal (GI) upsets such as constipation, diarrhea and sensitivity to foods six-to-eight times more often than do children who are developing typically, and those symptoms are related to behavioral problems, including social withdrawal, irritability and repetitive behaviors, a new study by researchers at the UC Davis MIND Institute has found. [en español] [中文 Chinese]
November 6, 2013
Percy Learns to Fly, a children’s book by Patricia Schetter, project coordinator at the Center for Excellence in Developmental Disabilities at the UC Davis MIND Institute, has received a gold medal for outstanding contributions to children’s literature in the 2013 Gelett Burgess Children’s Book Award competition.
October 25, 2013
James C. McPartland, director of the Developmental Disabilities Clinic at the Child Study Center at Yale University, will discuss “Motivated for Change: Rethinking Models of Social Brain Development in Autism Spectrum Disorder” during the November UC Davis MIND Institute Distinguished Lecturer Series presentation. The lecture will be held on Wednesday, Nov. 13, from 4:30 p.m. to 6 p.m. in the auditorium of the MIND Institute, 2825 50th St., Sacramento.
October 15, 2013
Jacqueline Crawley, the Robert E. Chason Endowed Chair in Translational Research in the Department of Psychiatry and Behavioral Sciences, will participate in the Preclinical Autism Consortium for Therapeutics (PACT), a new partnership sponsored by Autism Speaks to facilitate the discovery of effective treatments for individuals with autism spectrum disorder. Other collaborators in the initiative are at Boston Children's Hospital and at the Baylor College of Medicine in Houston.
October 10, 2013
The 2013-14 season of the UC Davis MIND Institute's Minds Behind the MIND series begins in November with nationally recognized MIND Institute researchers partnering with community representatives to provide the latest information on attention-deficit/hyperactivity disorder (ADHD), one of many neurodevelopmental disabilities studied at the MIND Institute. Subsequent presentations focus on how technology can aid people with developmental disabilities and on new findings in autism treatments.
UC Davis study finds potential biomarker differentiating the inattentive and combined subtypes of ADHD
October 8, 2013
Using a common test of brain functioning, UC Davis researchers have found differences in the brains of adolescents with the inattentive and combined subtypes of attention-deficit/hyperactivity disorder (ADHD) and teens who do not have the condition, suggesting that the test may offer a potential biomarker for the types of the disorder. [中文 Chinese] or [en español]
October 7, 2013
Researchers at the UC Davis MIND Institute will participate in an international consortium spanning four continents that will study the genetics of schizophrenia and other psychiatric disorders in chromosome 22q11.2 deletion syndrome through a four-year, $12 million grant from the National Institute of Mental Health to the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
September 23, 2013
The UC Davis MIND Institute begins the 12th year of its Distinguished Lecturer Series on Wednesday, Oct. 9. The venerable series' presenters include nationally and internationally recognized researchers in autism spectrum disorder, fragile X-associated disorders and other neurodevelopmental conditions.
UC Davis researchers find how viral infection disrupts neural development in offspring, increasing risk of autism
September 19, 2013
Activating a mother’s immune system during her pregnancy disrupts the development of neural cells in the brain of her offspring and damages the cells' ability to transmit signals and communicate with one another, researchers with the Center for Neuroscience and Department of Neurology have found. The researchers said the finding suggests how maternal viral infection might increase the risk of having a child with autism spectrum disorder or schizophrenia.
September 19, 2013
Jacqueline N. Crawley, an internationally renowned behavioral neuroscientist, has received a five-year, nearly $3 million grant from the National Institutes of Health to understand the synaptic dysfunctions that limit how people with certain neurodevelopmental disorders form memories and learn. The research also will investigate the effectiveness of potential targeted therapies for the disorders: fragile X syndrome, Rett syndrome, Down syndrome and Angelman syndrome.
September 17, 2013
Children with a genetic disorder called 22q11.2 deletion syndrome, who frequently are believed to also have autism, often may be misidentified because the social impairments associated with their developmental delay may mimic the features of autism, a study by researchers with the UC Davis MIND Institute suggests.
September 3, 2013
Using a virtual‐reality game, UC Davis researchers have begun to examine how children with high‐functioning autism learn in classroom settings, where social deficits can form obstacles to the engagement with teachers and classmates necessary for academic success. The study will examine their virtual classroom behavior and attention and compare it with that of children with attention-deficit/hyperactivity disorder (ADHD) and those with typical development.
August 5, 2013
UC Davis researchers have identified how and where in the genome a cancer chemotherapy agent acts on and ‘un-silences’ the epigenetically silenced gene that causes Angelman syndrome, a rare neurodevelopmental disorder characterized by severe intellectual disability, seizures, motor impairments, and laughing and smiling.
August 1, 2013
Environmental epidemiologist Irva Hertz-Picciotto, UC Davis professor of public health sciences, has been appointed to the Neurological, Aging and Musculoskeletal Epidemiology (NAME) Study Section of the Center for Scientific Review of the National Institutes of Health (NIH). The appointment is effective immediately and ends in June 2017.
July 18, 2013
Researchers at the UC Davis MIND Institute are seeking adolescents to participate in a groundbreaking brain imaging study aimed at understanding one of the most critical aspects of autism spectrum disorders: how people with autism generalize things they learn to new contexts.
Excessive cerebrospinal fluid and enlarged brain size in infancy are potential biomarkers for autism
July 9, 2013
Children who were later diagnosed with autism spectrum disorder had excessive cerebrospinal fluid and enlarged brains in infancy, a study by a multidisciplinary team of researchers with the UC Davis MIND Institute has found, raising the possibility that those brain anomalies may serve as potential biomarkers for the early identification of the neurodevelopmental disorder. [en español or 中文 Chinese]
UC Davis MIND Institute researchers find exposure to prenatal maternal antibodies affects behavior, development in offspring
July 9, 2013
Researchers with the UC Davis MIND Institute have found that prenatal exposure to specific antibodies found only in mothers of children with autism leads to changes in the brain that adversely affect behavior and development. [en español]
UC Davis MIND Institute researchers identify specific fetal antigens attacked by maternal antibodies
July 9, 2013
UC Davis MIND Institute researchers have identified the specific antibodies that target fetal brain proteins in the blood of a subset of women whose children are diagnosed with autism. The finding is the first to pinpoint a specific risk factor for a significant subset of autism cases, as well as a biomarker for drug development and early diagnosis. The researchers have named autism related to these antibodies “Maternal Autoantibody-Related," or MAR autism. [en español] [中文 Chinese]
June 26, 2013
UC Davis holds its annual Summer Institute on Neurodevelopmental Disorders: Research to Practice on Friday, Aug. 2, from 8:30 a.m. to 5 p.m. at the UC Davis Conference Center. The daylong conference offers nine interactive seminars on a broad array of subjects by some of the world’s leading experts on neurodevelopmental disabilities.
June 25, 2013
Researchers with the UC Davis MIND Institute and Agilent Laboratories have found that Prader-Willi syndrome — a genetic disorder best known for causing an insatiable appetite that can lead to morbid obesity — is associated with the loss of non-coding RNAs, resulting in the dysregulation of circadian and metabolic genes, accelerated energy expenditure and metabolic differences during sleep.
May 24, 2013
Robert Hales, chair of the Department of Psychiatry and Behavioral Sciences, has been named a Health Care Hero by the Sacramento Business Journal. The honor was announced today.
May 22, 2013
Researchers at the UC Davis MIND Institute and the UC Davis Center for Mind and Brain have received a five-year, $3 million grant from the National Institute of Mental Health to conduct the first long-range study of the mental and psychological decline that accompanies the age-related neurological disorder fragile X-associated tremor/ataxia syndrome, or FXTAS.
May 2, 2013
UC Davis Professor of Psychiatry and Behavioral Sciences David Amaral, director of research at the UC Davis MIND Institute, will be the first director of a new network of sites that will collect and disseminate autism brain tissue to advance research in the field.
April 24, 2013
A study by researchers at the UC Davis MIND Institute and the Yale University School of Medicine has found that more than 95 percent of the placentas of infants who are among those at the greatest risk for developing autism contained abnormal cells, called trophoblast inclusions, suggesting that the abnormality may hold promise as a very early marker for autism risk.
April 22, 2013
Epidemiologist Craig Newschaffer of Drexel University will discuss "Autism Outcomes and Risk Factors: What Can We Learn from Health-Care Claims?” during the next UC Davis MIND Institute Distinguished Lecturer Series presentation.
April 8, 2013
Minocycline, an older, broad-spectrum antibiotic in the tetracycline family, provides meaningful improvements as a therapeutic for children with fragile X syndrome, a study by researchers at the UC Davis MIND Institute has found. The finding is important, the researchers said, because minocycline is readily available by prescription.
UC Davis MIND Institute's Rogers receives prestigious Autism Centers of Excellence award from the NIH
April 2, 2013
Autism researchers at the UC Davis MIND Institute have received a prestigious $13 million award from the National Institutes of Health to establish an Autism Center of Excellence and Treatment Network, making the MIND Institute one of only nine such centers in the United States.
March 27, 2013
Bradley L. Schlaggar of the Washington University School of Medicine in St. Louis will discuss “Development of the Brain’s Functional Networks” during the next UC Davis MIND Institute Distinguished Lecturer Series presentation.
March 27, 2013
Researchers at UC Davis and the University of British Columbia have shed new light on methylation, a critical process that helps control how genes are expressed. Working with placentas, the team discovered that 37 percent of the placental genome has regions of lower methylation, called partially methylated domains (PMDs), in which gene expression is turned off. This differs from most human tissues, in which 70 percent of the genome is highly methylated.
March 26, 2013
A team of researchers led by UC Davis MIND Institute Director Leonard Abbeduto will investigate the effectiveness of testing procedures to examine the spoken language development of people with fragile X syndrome and people with Down syndrome, through a new five-year, $3 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.
March 5, 2013
April is National Autism Awareness Month and the UC Davis MIND Institute, an institute respected internationally for its groundbreaking research into therapies for autism and other neurodevelopmental disorders, is holding a series of free, inclusive events in recognition of the month-long observance. The events also mark the 15-year anniversary of the MIND Institute, founded in 1998.
March 5, 2013
Sally J. Rogers, UC Davis professor of psychiatry and behavioral sciences, was honored on Monday during the Breaking the Glass Ceiling Awards of the California Legislative Women’s Caucus. The awards celebrate the successes of California women in breaking barriers in the fields of science, technology, the arts, the judiciary and beyond. The ceremony was part of the Assembly’s celebration of Women’s History Month during the Floor Session.
February 26, 2013
In a surprise breakthrough, researchers at the UC Davis MIND Institute and their colleagues have found that microglia remove healthy neural progenitor cells (NPCs) through phagocytosis to control neuron production during brain development. This newly discovered mechanism keeps neuron numbers in check, preventing brain overgrowth. The discovery could open up new avenues for brain research and lead to therapies for a variety of neurological conditions.
February 25, 2013
Neurobiologist Paul Patterson, the Anne P. and Benjamin F. Biaggini Professor of Biological Sciences at the California Institute of Technology in Pasadena, will discuss “Gut-Brain-Immune Connections: Modeling an Environmental Risk Factor for Autism,” during the next UC Davis MIND Institute Distinguished Lecturer Series presentation.
January 31, 2013
Catherine Lord, director of the Center for Autism and the Developing Brain, will discuss “Longitudinal Studies of Autism Spectrum Disorder” during the next UC Davis MIND Institute Distinguished Lecturer Series presentation.
January 16, 2013
A common ingredient in flame retardants, BDE-49 accumulates in human blood, fat and breast milk. Despite these concentrations, little research has been done on the chemical’s potential health risks. However, a study by scientists at the UC Davis MIND Institute is shedding new light on BDE-49’s potential danger to brain health. The study showed that even tiny amounts of the compound damage neural mitochondria, the energy plants that power our cells. The chemical, quite literally, reduces brain power.
January 11, 2013
Two internationally respected UC Davis MIND Institute researchers have received grants from Autism Speaks, a national autism advocacy and science organization, to study autism from two different perspectives.
January 10, 2013
UC Davis Professors Paul and Randi Hagerman have devoted their lives to finding cures for a host of disorders that all spring from an inherited defect on the X chromosome that causes lifelong intellectual disability in children, tremors in older men and reproductive problems in women.
January 7, 2013
Recent estimates place the prevalence of Down syndrome at 1 in 691 births, making it the leading known genetic cause of intellectual disability. During the January UC Davis MIND Institute “Minds Behind the MIND” presentation, researchers will provide an update on what is known about Down syndrome, its impact on the individual and their family, and possible treatments.
January 3, 2013
Wendy L. Stone, director and Susan & Richard Fade Endowed Chair at the University of Washington Autism Center in Seattle, will discuss “From Early Detection to Early Intervention: Bridging the Gap in Autism Services” during the next UC Davis MIND Institute Distinguished Lecturer Series presentation.